Swayampakula Ramakanth

May 04, 2026

Swayampakula Ramakanth rated CELC as Buy on May 04, 2026, setting a price target of 165. Shares have remained stable near 144.98, leaving the 165 target still in play.

May 04, 2026

On May 04, 2026, MIRM was given a Buy rating by Swayampakula Ramakanth, with a target price of 175. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

May 04, 2026

CORT received a Buy rating from Swayampakula Ramakanth on May 04, 2026, aiming for 75. Price action was muted, as shares hovered around 51.6 despite the bullish outlook.

Apr 24, 2026

On Apr 24, 2026, Swayampakula Ramakanth published a Buy outlook on EVAX, with a target of 16. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 4.57.

Apr 22, 2026

Swayampakula Ramakanth on Apr 22, 2026 assigned ACTU a Buy rating, with a price target of 15. The Buy call aligned well with market performance, producing a gain of 6.12%.

Apr 21, 2026

On Apr 21, 2026, Swayampakula Ramakanth reaffirmed NUVL with a Buy rating, targeting 155. Market indecision has kept the 155 target in a holding pattern.

Apr 15, 2026

VOR was rated Buy by Swayampakula Ramakanth on Apr 15, 2026, with a price objective of 31. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Apr 09, 2026

On Apr 09, 2026, Swayampakula Ramakanth initiated coverage on EDAP with a Buy rating and target of 10. Neutral price movement of -0.60% leaves room for interpretation.

Apr 08, 2026

Swayampakula Ramakanth issued a Buy recommendation for RNXT on Apr 08, 2026, price target set at 3. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Apr 07, 2026

On Apr 07, 2026, IPHA was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 5. This case illustrates how a timely bullish rating can translate into tangible gains of 5.93%.

Mar 26, 2026

Swayampakula Ramakanth rated PGEN as Buy on Mar 26, 2026, setting a price target of 10. Shares have remained stable near 4.14, leaving the 10 target still in play.

Mar 25, 2026

On Mar 25, 2026, OCGN was given a Buy rating by Swayampakula Ramakanth, with a target price of 10. Despite the Buy call, shares fell from 1.85 to 1.85, challenging the optimistic stance.

Mar 24, 2026

PYXS received a Buy rating from Swayampakula Ramakanth on Mar 24, 2026, aiming for 7. Momentum has favored the Buy call, with shares climbing from 1.76 to 1.76, rewarding those who trusted the recommendation.

Mar 20, 2026

On Mar 20, 2026, Swayampakula Ramakanth published a Buy outlook on ETON, with a target of 52. Shares gained 35.13%, underscoring the accuracy of the bullish outlook toward 52.

Mar 19, 2026

Swayampakula Ramakanth on Mar 19, 2026 assigned LFWD a Buy rating, with a price target of 10. The recommendation remains pending validation as shares consolidate around 7.075.

Mar 13, 2026

On Mar 13, 2026, Swayampakula Ramakanth reaffirmed INAB with a Buy rating, targeting 6. Shares slid 14.81% despite the recommendation, highlighting downside risks.

Mar 10, 2026

ALXO was rated Buy by Swayampakula Ramakanth on Mar 10, 2026, with a price objective of 4. This case shows how bullish projections can fail, with the stock now below 1.88.

Mar 09, 2026

On Mar 09, 2026, Swayampakula Ramakanth initiated coverage on DNTH with a Buy rating and target of 130. The stock’s climb of 12.76% since the call highlights the foresight in the rating.

Feb 27, 2026

Swayampakula Ramakanth issued a Buy recommendation for VCEL on Feb 27, 2026, price target set at 64. The target of 64 remains in play, though confirmation will depend on future moves.

Jan 26, 2026

On Jan 26, 2026, ECOR was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 18. Investors saw limited payoff as shares fell short of the 18 target.

Jan 09, 2026

Swayampakula Ramakanth rated DCTH as Buy on Jan 09, 2026, setting a price target of 30. The call has proven timely, with shares rising 6.58% toward the price target of 30.

Jan 07, 2026

On Jan 07, 2026, CGEN was given a Buy rating by Swayampakula Ramakanth, with a target price of 4. The stock rallied 53.49% after the rating, narrowing the gap to the target of 4 and validating the bullish stance.

Dec 18, 2025

On Dec 18, 2025, Swayampakula Ramakanth published a Buy outlook on ABSI, with a target of 8. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 5.62.

Dec 02, 2025

Swayampakula Ramakanth on Dec 02, 2025 assigned JANX a Buy rating, with a price target of 70. The call has struggled to gain traction, with shares losing 9.08%.

Nov 21, 2025

On Nov 21, 2025, Swayampakula Ramakanth reaffirmed MDWD with a Buy rating, targeting 36. Market indecision has kept the 36 target in a holding pattern.

Nov 11, 2025

PSNL was rated Buy by Swayampakula Ramakanth on Nov 11, 2025, with a price objective of 13. This case shows how bullish projections can fail, with the stock now below 5.9.

Nov 10, 2025

On Nov 10, 2025, Swayampakula Ramakanth initiated coverage on XFOR with a Buy rating and target of 5. The stock’s climb of 15.98% since the call highlights the foresight in the rating.

Nov 04, 2025

Swayampakula Ramakanth issued a Buy recommendation for CANF on Nov 04, 2025, price target set at 2.5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Oct 29, 2025

On Oct 29, 2025, UNCY was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 22. This case illustrates how a timely bullish rating can translate into tangible gains of 66.25%.

Oct 23, 2025

Swayampakula Ramakanth rated DYAI as Buy on Oct 23, 2025, setting a price target of 3. The stock has underperformed, dropping 36.36% despite the bullish target of 3.

Aug 21, 2025

On Aug 21, 2025, CLGN was given a Buy rating by Swayampakula Ramakanth, with a target price of 11. Despite the Buy call, shares fell from 0.418 to 0.418, challenging the optimistic stance.

Aug 12, 2025

On Aug 12, 2025, Swayampakula Ramakanth published a Buy outlook on HUMA, with a target of 3. Market action contradicted the Buy thesis, as shares slipped to 0.9248.

May 19, 2025

Swayampakula Ramakanth on May 19, 2025 assigned QSI a Buy rating, with a price target of null. The call has struggled to gain traction, with shares losing 31.10%.

Apr 02, 2025

On Apr 02, 2025, Swayampakula Ramakanth reaffirmed MDAI with a Buy rating, targeting 3.5. The recommendation was supported by strong follow-through as the stock rose from 2.27 to 2.27.

Mar 31, 2025

IPA was rated Buy by Swayampakula Ramakanth on Mar 31, 2025, with a price objective of 5. A bullish response from the market helped close the gap of 3.38 to the target.

Mar 21, 2025

Swayampakula Ramakanth issued a Buy recommendation for ELEV on Mar 21, 2025, price target set at 1. Investors following the Buy call captured upside momentum, with shares now at 0.365.

Mar 06, 2025

On Mar 06, 2025, ITOS was evaluated by Swayampakula Ramakanth, who gave a Buy rating and target of 46. This case illustrates how a timely bullish rating can translate into tangible gains of 42.96%.

Feb 26, 2025

Swayampakula Ramakanth rated BCYC as Buy on Feb 26, 2025, setting a price target of 33. The stock has underperformed, dropping 56.36% despite the bullish target of 33.

Dec 10, 2024

On Dec 10, 2024, AFMD was given a Buy rating by Swayampakula Ramakanth, with a target price of 10. Despite the Buy call, shares fell from 0.1815 to 0.1815, challenging the optimistic stance.

Dec 06, 2024

MDNA received a Buy rating from Swayampakula Ramakanth on Dec 06, 2024, aiming for 2.5. Price action was muted, as shares hovered around 0.157 despite the bullish outlook.

Nov 21, 2024

On Nov 21, 2024, Swayampakula Ramakanth published a Buy outlook on INTS, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 5.2.

May 01, 2024

MDXG was rated Buy by Swayampakula Ramakanth on May 01, 2024, with a price objective of 11. This case shows how bullish projections can fail, with the stock now below 3.61.